MPD: Phenotype measures mapped to MP:0021121, abnormal rhythmic behavior

Phenotype measures in CSNA03 associated with ontology term
MP:0021121 'abnormal rhythmic behavior'

All measures in this list are mapped to the ontology descendants of MP:0021121. None are mapped to MP:0021121 directly.

MP:0020467 abnormal circadian behavior

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
CSNA03:685	CSNA03	in vitro assay	(none)	peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders [h] period_in 112539	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:686	CSNA03	in vitro assay	(none)	peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h] period_cc 112544	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:688	CSNA03	in vitro assay	(none)	specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders [n] phase_in 112540	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:689	CSNA03	in vitro assay	(none)	specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n] phase_cc 112545	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:691	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders [n/s] amplitude_in 112541	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:692	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:694	CSNA03	in vitro assay	(none)	number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders [days] damping_in 112542	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:695	CSNA03	in vitro assay	(none)	number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC [days] damping_cc 112547	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:697	CSNA03	in vitro assay	(none)	percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, founders [%] goodness_of_fit_in 112543	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:698	CSNA03	in vitro assay	(none)	percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC [%] goodness_of_fit_cc 112548	CC w/par	40	both	8-12wks	N=4	2020

Filter Table Results